{"transactions":[{"id":4638434,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":67955,"kind":"person","name":"Degnan Chris","position":1,"cik":"0001741968","reported_name":"Degnan Chris","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-10-09T16:57:06.000Z","date":"2026-10-08","kind":"exercise","planned":false,"acquired":false,"shares":4483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025."}],"balance_after":4484,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4483},"source":{"system":"sec-edgar","filing":"0001437749-26-032421","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1741968/000143774926032421/rdgdoc.xml","form_type":"4"}},{"id":4638433,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":67955,"kind":"person","name":"Degnan Chris","position":1,"cik":"0001741968","reported_name":"Degnan Chris","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-10-09T16:57:06.000Z","date":"2026-10-08","kind":"sale","planned":false,"acquired":false,"shares":2202,"price":36.69,"value":80791.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":4561,"source":{"system":"sec-edgar","filing":"0001437749-26-032421","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741968/000143774926032421/rdgdoc.xml","form_type":"4"}},{"id":4638432,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":67955,"kind":"person","name":"Degnan Chris","position":1,"cik":"0001741968","reported_name":"Degnan Chris","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-10-09T16:57:06.000Z","date":"2026-10-08","kind":"exercise","planned":false,"acquired":true,"shares":4483,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":6763,"source":{"system":"sec-edgar","filing":"0001437749-26-032421","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741968/000143774926032421/rdgdoc.xml","form_type":"4"}},{"id":4613217,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-09-09T18:37:16.000Z","date":"2026-09-07","kind":"exercise","planned":false,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001437749-26-029965","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926029965/rdgdoc.xml","form_type":"4"}},{"id":4613216,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-09T18:37:16.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":871,"price":42.92,"value":37383.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":59882,"source":{"system":"sec-edgar","filing":"0001437749-26-029965","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926029965/rdgdoc.xml","form_type":"4"}},{"id":4613215,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-09T18:37:16.000Z","date":"2026-09-07","kind":"exercise","planned":false,"acquired":true,"shares":1667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":60753,"source":{"system":"sec-edgar","filing":"0001437749-26-029965","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926029965/rdgdoc.xml","form_type":"4"}},{"id":4613214,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-09-09T18:35:46.000Z","date":"2026-09-07","kind":"exercise","planned":false,"acquired":false,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001437749-26-029963","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821479/000143774926029963/rdgdoc.xml","form_type":"4"}},{"id":4613213,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-09-09T18:35:46.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":1519,"price":42.54,"value":64618.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":53141,"source":{"system":"sec-edgar","filing":"0001437749-26-029963","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821479/000143774926029963/rdgdoc.xml","form_type":"4"}},{"id":4613212,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-09-09T18:35:46.000Z","date":"2026-09-07","kind":"exercise","planned":false,"acquired":true,"shares":3334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":54660,"source":{"system":"sec-edgar","filing":"0001437749-26-029963","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821479/000143774926029963/rdgdoc.xml","form_type":"4"}},{"id":672952,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":18718,"kind":"person","name":"Robinson James A. Jr.","position":1,"cik":"0001734295","reported_name":"Robinson James A. Jr.","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2026-08-28T16:01:41.000Z","date":"2026-08-26","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001437749-26-029175","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926029175/rdgdoc.xml","form_type":"4"}},{"id":672951,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":18718,"kind":"person","name":"Robinson James A. Jr.","position":1,"cik":"0001734295","reported_name":"Robinson James A. Jr.","relationship":{"director":true}}],"security":"ordinary shares","published_at":"2026-08-28T16:01:41.000Z","date":"2026-08-26","kind":"exercise","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001437749-26-029175","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926029175/rdgdoc.xml","form_type":"4"}},{"id":677450,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"ordinary shares","published_at":"2026-08-24T21:03:17.000Z","date":"2026-08-20","kind":"sale","planned":false,"acquired":false,"shares":60677,"price":47.05,"value":2854852.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.30 to $49.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":59086,"source":{"system":"sec-edgar","filing":"0001437749-26-028840","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926028840/rdgdoc.xml","form_type":"4"}},{"id":711210,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-10T18:17:40.000Z","date":"2026-07-09","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":40,"value":400000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a duly adopted trading plan under Rule 10b5-1(c). The adoption date of the referenced Rule 10b5-1(c) plan is August 15, 2025. This transaction represents the final sale under such trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 and $40.02. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":119763,"source":{"system":"sec-edgar","filing":"0001437749-26-023290","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926023290/rdgdoc.xml","form_type":"4"}},{"id":727737,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-24T14:22:49.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":35.01,"value":350100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). Adoption date of referenced 10b5-1(c) plan is: 08-15-2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 and $35.08. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":129763,"source":{"system":"sec-edgar","filing":"0001437749-26-021523","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926021523/rdgdoc.xml","form_type":"4"}},{"id":727630,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2026-06-24T14:03:57.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":8000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001437749-26-021519","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926021519/rdgdoc.xml","form_type":"4"}},{"id":727629,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2026-06-24T14:03:57.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":10000,"derivative":{"exercise_price":34.99,"expiration_date":"2036-06-22","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-26-021519","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926021519/rdgdoc.xml","form_type":"4"}},{"id":727628,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":18718,"kind":"person","name":"Robinson James A. Jr.","position":1,"cik":"0001734295","reported_name":"Robinson James A. Jr.","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2026-06-24T14:02:42.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":8000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001437749-26-021517","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926021517/rdgdoc.xml","form_type":"4"}},{"id":727627,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":18718,"kind":"person","name":"Robinson James A. Jr.","position":1,"cik":"0001734295","reported_name":"Robinson James A. Jr.","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2026-06-24T14:02:42.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":10000,"derivative":{"exercise_price":34.99,"expiration_date":"2036-06-22","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-26-021517","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926021517/rdgdoc.xml","form_type":"4"}},{"id":727626,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":33881,"kind":"person","name":"BUTITTA CYNTHIA M","position":1,"cik":"0001222082","reported_name":"BUTITTA CYNTHIA M","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2026-06-24T14:00:08.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":8000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001437749-26-021513","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926021513/rdgdoc.xml","form_type":"4"}},{"id":727625,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":33881,"kind":"person","name":"BUTITTA CYNTHIA M","position":1,"cik":"0001222082","reported_name":"BUTITTA CYNTHIA M","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2026-06-24T14:00:08.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":10000,"derivative":{"exercise_price":34.99,"expiration_date":"2036-06-22","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-26-021513","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926021513/rdgdoc.xml","form_type":"4"}},{"id":727624,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":27151,"kind":"person","name":"WEN LEANA","position":1,"cik":"0001847598","reported_name":"WEN LEANA","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2026-06-24T13:58:49.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":8000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001437749-26-021511","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926021511/rdgdoc.xml","form_type":"4"}},{"id":727623,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":27151,"kind":"person","name":"WEN LEANA","position":1,"cik":"0001847598","reported_name":"WEN LEANA","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2026-06-24T13:58:49.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":10000,"derivative":{"exercise_price":34.99,"expiration_date":"2036-06-22","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-26-021511","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926021511/rdgdoc.xml","form_type":"4"}},{"id":727622,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35650,"kind":"person","name":"Belldegrun Arie","position":1,"cik":"0001296549","reported_name":"Belldegrun Arie","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2026-06-24T13:57:31.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":20000,"derivative":{"exercise_price":34.99,"expiration_date":"2036-06-22","underlying":"Ordinary Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-021509","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926021509/rdgdoc.xml","form_type":"4"}},{"id":727736,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35677,"kind":"person","name":"Holden Stuart","position":1,"cik":"0001763999","reported_name":"Holden Stuart","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2026-06-24T10:01:21.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":20000,"derivative":{"exercise_price":34.99,"expiration_date":"2036-06-22","underlying":"Ordinary Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-021515","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763999/000143774926021515/rdgdoc.xml","form_type":"4"}},{"id":744711,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-09T17:59:59.000Z","date":"2026-06-08","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-26-019964","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926019964/rdgdoc.xml","form_type":"4"}},{"id":744710,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-09T17:59:59.000Z","date":"2026-06-08","kind":"sale","planned":false,"acquired":false,"shares":5222,"price":27.3,"value":142560.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":139763,"source":{"system":"sec-edgar","filing":"0001437749-26-019964","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926019964/rdgdoc.xml","form_type":"4"}},{"id":744709,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-09T17:59:59.000Z","date":"2026-06-08","kind":"exercise","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":144985,"source":{"system":"sec-edgar","filing":"0001437749-26-019964","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926019964/rdgdoc.xml","form_type":"4"}},{"id":761798,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":18718,"kind":"person","name":"Robinson James A. Jr.","position":1,"cik":"0001734295","reported_name":"Robinson James A. Jr.","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2026-05-27T12:04:51.000Z","date":"2026-05-26","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":2000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001437749-26-018442","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926018442/rdgdoc.xml","form_type":"4"}},{"id":761797,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":18718,"kind":"person","name":"Robinson James A. Jr.","position":1,"cik":"0001734295","reported_name":"Robinson James A. Jr.","relationship":{"director":true}}],"security":"ordinary shares","published_at":"2026-05-27T12:04:51.000Z","date":"2026-05-26","kind":"exercise","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001437749-26-018442","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926018442/rdgdoc.xml","form_type":"4"}},{"id":784816,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-05-11T19:54:04.000Z","date":"2026-05-08","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":30,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). Adoption date of referenced 10b5-1(c) plan is: 08-15-2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 and $30.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":134985,"source":{"system":"sec-edgar","filing":"0001437749-26-016104","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926016104/rdgdoc.xml","form_type":"4"}},{"id":877285,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":18718,"kind":"person","name":"Robinson James A. Jr.","position":1,"cik":"0001734295","reported_name":"Robinson James A. Jr.","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:44:12.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":4000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001437749-26-006124","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926006124/rdgdoc.xml","form_type":"4"}},{"id":877284,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":18718,"kind":"person","name":"Robinson James A. Jr.","position":1,"cik":"0001734295","reported_name":"Robinson James A. Jr.","relationship":{"director":true}}],"security":"ordinary shares","published_at":"2026-02-27T21:44:12.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001437749-26-006124","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926006124/rdgdoc.xml","form_type":"4"}},{"id":893349,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T15:46:23.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":153195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029."}],"balance_after":153195,"derivative":{"underlying":"Ordinary Shares","underlying_shares":153195},"source":{"system":"sec-edgar","filing":"0001437749-26-004638","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926004638/rdgdoc.xml","form_type":"4"}},{"id":909928,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T19:54:58.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":32609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029."}],"balance_after":32609,"derivative":{"underlying":"Ordinary Shares","underlying_shares":32609},"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909927,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T19:54:58.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909926,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T19:54:58.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2025 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2025 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026."}],"balance_after":6667,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909925,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T19:54:58.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025."}],"balance_after":5500,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909924,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-02-11T19:54:58.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":3217,"price":19.69,"value":63342.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":55588,"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909923,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-02-11T19:54:58.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":6667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":49972,"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909922,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-02-11T19:54:58.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":1608,"price":19.69,"value":31661.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":51326,"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909921,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-02-11T19:54:58.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":3333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":58805,"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909920,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-02-11T19:54:58.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":2654,"price":19.69,"value":52257.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":52934,"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909919,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-02-11T19:54:58.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":55472,"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":919480,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-05T00:37:34.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":3686,"price":19.69,"value":72577.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":144985,"source":{"system":"sec-edgar","filing":"0001437749-26-003040","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926003040/rdgdoc.xml","form_type":"4"}},{"id":919479,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-05T00:37:34.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":1843,"price":19.69,"value":36288.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":148671,"source":{"system":"sec-edgar","filing":"0001437749-26-003040","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926003040/rdgdoc.xml","form_type":"4"}},{"id":919478,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-05T00:37:34.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":1844,"price":19.69,"value":36308.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":150514,"source":{"system":"sec-edgar","filing":"0001437749-26-003040","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926003040/rdgdoc.xml","form_type":"4"}},{"id":922005,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T22:18:26.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029."}],"balance_after":20000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-002843","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926002843/rdgdoc.xml","form_type":"4"}},{"id":922004,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T22:18:26.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001437749-26-002843","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926002843/rdgdoc.xml","form_type":"4"}},{"id":922003,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T22:18:26.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted RSUs on January 31, 2025 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person was granted RSUs on January 31, 2025 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026."}],"balance_after":13334,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6666},"source":{"system":"sec-edgar","filing":"0001437749-26-002843","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926002843/rdgdoc.xml","form_type":"4"}},{"id":922002,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T22:18:26.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2024 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2024 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025."}],"balance_after":3334,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001437749-26-002843","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926002843/rdgdoc.xml","form_type":"4"}},{"id":922001,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-03T22:18:26.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":3334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":142359,"source":{"system":"sec-edgar","filing":"0001437749-26-002843","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926002843/rdgdoc.xml","form_type":"4"}},{"id":922000,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-03T22:18:26.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":6666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":152358,"source":{"system":"sec-edgar","filing":"0001437749-26-002843","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926002843/rdgdoc.xml","form_type":"4"}},{"id":921999,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-03T22:18:26.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":3333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":145692,"source":{"system":"sec-edgar","filing":"0001437749-26-002843","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774926002843/rdgdoc.xml","form_type":"4"}},{"id":921848,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":67955,"kind":"person","name":"Degnan Chris","position":1,"cik":"0001741968","reported_name":"Degnan Chris","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T22:16:53.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":32609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029."}],"balance_after":32609,"derivative":{"underlying":"Ordinary Shares","underlying_shares":32609},"source":{"system":"sec-edgar","filing":"0001437749-26-002841","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926002841/rdgdoc.xml","form_type":"4"}},{"id":985074,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":33881,"kind":"person","name":"BUTITTA CYNTHIA M","position":1,"cik":"0001222082","reported_name":"BUTITTA CYNTHIA M","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-12-01T21:52:32.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":6000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001437749-25-036565","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925036565/rdgdoc.xml","form_type":"4"}},{"id":985073,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":33881,"kind":"person","name":"BUTITTA CYNTHIA M","position":1,"cik":"0001222082","reported_name":"BUTITTA CYNTHIA M","relationship":{"director":true}}],"security":"ordinary shares","published_at":"2025-12-01T21:52:32.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001437749-25-036565","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925036565/rdgdoc.xml","form_type":"4"}},{"id":985072,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":18718,"kind":"person","name":"Robinson James A. Jr.","position":1,"cik":"0001734295","reported_name":"Robinson James A. Jr.","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-12-01T21:47:46.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":6000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001437749-25-036559","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925036559/rdgdoc.xml","form_type":"4"}},{"id":985071,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":18718,"kind":"person","name":"Robinson James A. Jr.","position":1,"cik":"0001734295","reported_name":"Robinson James A. Jr.","relationship":{"director":true}}],"security":"ordinary shares","published_at":"2025-12-01T21:47:46.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001437749-25-036559","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925036559/rdgdoc.xml","form_type":"4"}},{"id":985070,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":27151,"kind":"person","name":"WEN LEANA","position":1,"cik":"0001847598","reported_name":"WEN LEANA","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-12-01T21:46:19.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":6000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001437749-25-036557","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925036557/rdgdoc.xml","form_type":"4"}},{"id":985069,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":27151,"kind":"person","name":"WEN LEANA","position":1,"cik":"0001847598","reported_name":"WEN LEANA","relationship":{"director":true}}],"security":"ordinary shares","published_at":"2025-12-01T21:46:19.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001437749-25-036557","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925036557/rdgdoc.xml","form_type":"4"}},{"id":985068,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-12-01T21:44:50.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":6000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001437749-25-036555","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925036555/rdgdoc.xml","form_type":"4"}},{"id":985067,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"ordinary shares","published_at":"2025-12-01T21:44:50.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001437749-25-036555","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925036555/rdgdoc.xml","form_type":"4"}},{"id":985143,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35677,"kind":"person","name":"Holden Stuart","position":1,"cik":"0001763999","reported_name":"Holden Stuart","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-12-01T17:17:44.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":6000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001437749-25-036576","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1763999/000143774925036576/rdgdoc.xml","form_type":"4"}},{"id":985142,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35677,"kind":"person","name":"Holden Stuart","position":1,"cik":"0001763999","reported_name":"Holden Stuart","relationship":{"director":true}}],"security":"ordinary shares","published_at":"2025-12-01T17:17:44.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001437749-25-036576","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763999/000143774925036576/rdgdoc.xml","form_type":"4"}},{"id":992566,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-11-20T18:42:12.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":25,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). Adoption date of referenced 10b5-1(c) plan is: 08-15-2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 and $25.02. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":139025,"source":{"system":"sec-edgar","filing":"0001437749-25-035821","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925035821/rdgdoc.xml","form_type":"4"}},{"id":1020831,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":67955,"kind":"person","name":"Degnan Chris","position":1,"cik":"0001741968","reported_name":"Degnan Chris","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-09T17:37:33.000Z","date":"2025-10-08","kind":"exercise","planned":false,"acquired":false,"shares":4483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025."}],"balance_after":8967,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4483},"source":{"system":"sec-edgar","filing":"0001437749-25-030772","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925030772/rdgdoc.xml","form_type":"4"}},{"id":1020830,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":67955,"kind":"person","name":"Degnan Chris","position":1,"cik":"0001741968","reported_name":"Degnan Chris","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-10-09T17:37:33.000Z","date":"2025-10-08","kind":"sale","planned":false,"acquired":false,"shares":2203,"price":16.85,"value":37120.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":2280,"source":{"system":"sec-edgar","filing":"0001437749-25-030772","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925030772/rdgdoc.xml","form_type":"4"}},{"id":1020829,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":67955,"kind":"person","name":"Degnan Chris","position":1,"cik":"0001741968","reported_name":"Degnan Chris","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-10-09T17:37:33.000Z","date":"2025-10-08","kind":"exercise","planned":false,"acquired":true,"shares":4483,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":4483,"source":{"system":"sec-edgar","filing":"0001437749-25-030772","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925030772/rdgdoc.xml","form_type":"4"}},{"id":1044861,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-09-09T22:37:09.000Z","date":"2025-09-07","kind":"exercise","planned":false,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."}],"balance_after":1667,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001437749-25-028707","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925028707/rdgdoc.xml","form_type":"4"}},{"id":1044860,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-09-09T22:37:09.000Z","date":"2025-09-08","kind":"sale","planned":false,"acquired":false,"shares":871,"price":19.11,"value":16644.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":149025,"source":{"system":"sec-edgar","filing":"0001437749-25-028707","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925028707/rdgdoc.xml","form_type":"4"}},{"id":1044859,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-09-09T22:37:09.000Z","date":"2025-09-07","kind":"exercise","planned":false,"acquired":true,"shares":1667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":149896,"source":{"system":"sec-edgar","filing":"0001437749-25-028707","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925028707/rdgdoc.xml","form_type":"4"}},{"id":1044771,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-09-09T22:32:09.000Z","date":"2025-09-07","kind":"exercise","planned":false,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."}],"balance_after":3334,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001437749-25-028705","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925028705/rdgdoc.xml","form_type":"4"}},{"id":1044770,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-09-09T22:32:09.000Z","date":"2025-09-08","kind":"sale","planned":false,"acquired":false,"shares":1520,"price":19.11,"value":29047.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":43305,"source":{"system":"sec-edgar","filing":"0001437749-25-028705","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925028705/rdgdoc.xml","form_type":"4"}},{"id":1044769,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-09-09T22:32:09.000Z","date":"2025-09-07","kind":"exercise","planned":false,"acquired":true,"shares":3333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":44825,"source":{"system":"sec-edgar","filing":"0001437749-25-028705","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925028705/rdgdoc.xml","form_type":"4"}},{"id":1054545,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-08-27T20:39:47.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":8000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001437749-25-027883","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925027883/rdgdoc.xml","form_type":"4"}},{"id":1054544,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35651,"kind":"person","name":"Wildman Daniel George","position":1,"cik":"0001952679","reported_name":"Wildman Daniel George","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2025-08-27T20:39:47.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":10000,"derivative":{"exercise_price":19.5,"expiration_date":"2035-08-26","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-027883","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925027883/rdgdoc.xml","form_type":"4"}},{"id":1054536,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":18718,"kind":"person","name":"Robinson James A. Jr.","position":1,"cik":"0001734295","reported_name":"Robinson James A. Jr.","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-08-27T20:39:09.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":8000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001437749-25-027882","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925027882/rdgdoc.xml","form_type":"4"}},{"id":1054535,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":18718,"kind":"person","name":"Robinson James A. Jr.","position":1,"cik":"0001734295","reported_name":"Robinson James A. Jr.","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2025-08-27T20:39:09.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":10000,"derivative":{"exercise_price":19.5,"expiration_date":"2035-08-26","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-027882","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925027882/rdgdoc.xml","form_type":"4"}},{"id":1054534,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":33881,"kind":"person","name":"BUTITTA CYNTHIA M","position":1,"cik":"0001222082","reported_name":"BUTITTA CYNTHIA M","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-08-27T20:37:58.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":8000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001437749-25-027879","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925027879/rdgdoc.xml","form_type":"4"}},{"id":1054533,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":33881,"kind":"person","name":"BUTITTA CYNTHIA M","position":1,"cik":"0001222082","reported_name":"BUTITTA CYNTHIA M","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2025-08-27T20:37:58.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":10000,"derivative":{"exercise_price":19.5,"expiration_date":"2035-08-26","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-027879","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925027879/rdgdoc.xml","form_type":"4"}},{"id":1054532,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":27151,"kind":"person","name":"WEN LEANA","position":1,"cik":"0001847598","reported_name":"WEN LEANA","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-08-27T20:37:16.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":8000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001437749-25-027878","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925027878/rdgdoc.xml","form_type":"4"}},{"id":1054531,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":27151,"kind":"person","name":"WEN LEANA","position":1,"cik":"0001847598","reported_name":"WEN LEANA","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2025-08-27T20:37:16.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":10000,"derivative":{"exercise_price":19.5,"expiration_date":"2035-08-26","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-027878","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925027878/rdgdoc.xml","form_type":"4"}},{"id":1054530,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35650,"kind":"person","name":"Belldegrun Arie","position":1,"cik":"0001296549","reported_name":"Belldegrun Arie","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2025-08-27T20:36:19.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":20000,"derivative":{"exercise_price":19.5,"expiration_date":"2035-08-26","underlying":"Ordinary Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-25-027877","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925027877/rdgdoc.xml","form_type":"4"}},{"id":1054573,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35677,"kind":"person","name":"Holden Stuart","position":1,"cik":"0001763999","reported_name":"Holden Stuart","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-08-27T16:38:46.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":8000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001437749-25-027880","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1763999/000143774925027880/rdgdoc.xml","form_type":"4"}},{"id":1054572,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35677,"kind":"person","name":"Holden Stuart","position":1,"cik":"0001763999","reported_name":"Holden Stuart","relationship":{"director":true}}],"security":"Stock Option (right ot buy)","published_at":"2025-08-27T16:38:46.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates."}],"balance_after":10000,"derivative":{"exercise_price":19.5,"expiration_date":"2035-08-26","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-027880","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763999/000143774925027880/rdgdoc.xml","form_type":"4"}},{"id":1067837,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-08-13T13:58:14.000Z","date":"2025-08-11","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":17.69,"value":176900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 and $17.76. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":148229,"source":{"system":"sec-edgar","filing":"0001437749-25-026377","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925026377/rdgdoc.xml","form_type":"4"}},{"id":1079098,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2025-07-30T20:08:22.000Z","date":"2025-07-28","kind":"grant","planned":false,"acquired":true,"shares":87615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents performance stock units (\"PSUs\") granted to the reporting person on January 31, 2024 that were earned upon the achievement of a corporate milestone event. These PSUs remain subject to continued service through December 31, 2025, at which time they will vest and settle in ordinary shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents performance stock units (\"PSUs\") granted to the reporting person on January 31, 2024 that were earned upon the achievement of a corporate milestone event. These PSUs remain subject to continued service through December 31, 2025, at which time they will vest and settle in ordinary shares."}],"balance_after":87615,"derivative":{"underlying":"Ordinary Shares","underlying_shares":87615},"source":{"system":"sec-edgar","filing":"0001437749-25-023969","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925023969/rdgdoc.xml","form_type":"4"}},{"id":1079097,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-07-30T20:03:45.000Z","date":"2025-07-28","kind":"sale","planned":false,"acquired":false,"shares":7522,"price":19.14,"value":143971.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of performance stock units."}],"balance_after":41492,"source":{"system":"sec-edgar","filing":"0001437749-25-023963","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925023963/rdgdoc.xml","form_type":"4"}},{"id":1079096,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-07-30T20:03:45.000Z","date":"2025-07-28","kind":"exercise","planned":false,"acquired":true,"shares":16500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the settlement of performance stock units granted on January 31, 2024 that vested upon the achievement of a corporate milestone event."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":49014,"source":{"system":"sec-edgar","filing":"0001437749-25-023963","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925023963/rdgdoc.xml","form_type":"4"}},{"id":1079167,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-07-30T20:02:05.000Z","date":"2025-07-28","kind":"sale","planned":false,"acquired":false,"shares":5149,"price":19.14,"value":98551.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of performance stock units."}],"balance_after":158229,"source":{"system":"sec-edgar","filing":"0001437749-25-023961","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925023961/rdgdoc.xml","form_type":"4"}},{"id":1079166,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-07-30T20:02:05.000Z","date":"2025-07-28","kind":"exercise","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the settlement of performance stock units granted on January 31, 2024 that vested upon the achievement of a corporate milestone event."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":163378,"source":{"system":"sec-edgar","filing":"0001437749-25-023961","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925023961/rdgdoc.xml","form_type":"4"}},{"id":1115059,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-11T13:14:14.000Z","date":"2025-06-08","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024."}],"balance_after":10000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-020045","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925020045/rdgdoc.xml","form_type":"4"}},{"id":1115058,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-06-11T13:14:14.000Z","date":"2025-06-09","kind":"sale","planned":false,"acquired":false,"shares":5162,"price":7.37,"value":38043.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":153378,"source":{"system":"sec-edgar","filing":"0001437749-25-020045","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925020045/rdgdoc.xml","form_type":"4"}},{"id":1115057,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-06-11T13:14:14.000Z","date":"2025-06-08","kind":"exercise","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":158540,"source":{"system":"sec-edgar","filing":"0001437749-25-020045","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925020045/rdgdoc.xml","form_type":"4"}},{"id":1284980,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T16:53:22.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2026, January 31, 2027 and January 31, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2026, January 31, 2027 and January 31, 2028."}],"balance_after":20000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-25-002688","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925002688/rdgdoc.xml","form_type":"4"}},{"id":1284979,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T16:53:22.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted RSUs on January 31, 2024 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The reporting person was granted RSUs on January 31, 2024 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025."}],"balance_after":6667,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001437749-25-002688","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925002688/rdgdoc.xml","form_type":"4"}},{"id":1284978,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T16:53:22.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024."}],"balance_after":3334,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001437749-25-002688","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925002688/rdgdoc.xml","form_type":"4"}},{"id":1284977,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T16:53:22.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":1334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2022 representing 4,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2022 representing 4,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1334},"source":{"system":"sec-edgar","filing":"0001437749-25-002688","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925002688/rdgdoc.xml","form_type":"4"}},{"id":1284976,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-04T16:53:22.000Z","date":"2025-01-31","kind":"sale","planned":false,"acquired":false,"shares":1896,"price":11.14,"value":21121.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":148540,"source":{"system":"sec-edgar","filing":"0001437749-25-002688","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925002688/rdgdoc.xml","form_type":"4"}},{"id":1284975,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":20367,"kind":"person","name":"Schoenberg Mark","position":1,"cik":"0001763581","reported_name":"Schoenberg Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-04T16:53:22.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":3333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":150436,"source":{"system":"sec-edgar","filing":"0001437749-25-002688","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1763581/000143774925002688/rdgdoc.xml","form_type":"4"}}],"next_cursor":"2025-02-04T16:53:22.000000Z,1284975"}